Tang Capital Management LLC Coherus Bio Sciences, Inc. Transaction History
Tang Capital Management LLC
- $1.54 Billion
- Q1 2025
A detailed history of Tang Capital Management LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 5,097,362 shares of CHRS stock, worth $4.54 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
5,097,362
Previous 3,650,000
39.65%
Holding current value
$4.54 Million
Previous $5.04 Million
18.05%
% of portfolio
0.27%
Previous 0.38%
Shares
11 transactions
Others Institutions Holding CHRS
# of Institutions
124Shares Held
64.5MCall Options Held
96.6KPut Options Held
65.3K-
Black Rock Inc. New York, NY11.8MShares$10.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.2MShares$9.93 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY5.26MShares$4.68 Million0.12% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$2.7 Million0.11% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.9MShares$2.58 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $69.2M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...